Q3 saw strong global comparable sales growth of 7.9% and margin expansion, despite a 1% revenue decline due to the China JV transition. EPS surged 86% (GAAP) and 70% (non-GAAP), and guidance was raised for FY26, with robust U.S. and global sales growth expected.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.